A global online study of haematopoietic stem cell transplantation in multiple sclerosis and other neurodegenerative disorders.

Peter K PanegyresJodi RussellHuei-Yang ChenMariella Panegyres

Published in: Chronic diseases and translational medicine (2022)

Participants were supportive of HSCT despite the costs and would recommend it to others. The data suggest some benefit in minimizing disability in MS and provides justification for large randomized controlled trials.

Keyphrases

multiple sclerosis
stem cell transplantation
high dose
randomized controlled trial
white matter
mass spectrometry
electronic health record
social media
low dose
systematic review
machine learning
meta analyses